Cassian Yee

Cassian Yee is a leader in developing personalized T cell therapies for cancer. His research focuses on isolating and expanding tumor-reactive T cells from patients, including both TILs and peripheral blood-derived T cells targeting specific tumor antigens. Yee has advanced manufacturing approaches that enhance T cell fitness and persistence for improved clinical outcomes.

Cassian Yee是开发个性化T细胞癌症治疗的领导者。他的研究专注于从患者中分离和扩增肿瘤反应性T细胞，包括TIL和靶向特定肿瘤抗原的外周血来源T细胞。Yee推进了增强T细胞适应性和持久性的制造方法，以改善临床结果。